Key points are not available for this paper at this time.
Endometrial Cancer (EC) is a highly heterogeneous cancer comprising both histological and molecular subtypes. Using a non-invasive modality method to trigger these subtypes as early as possible can aid clinicians in establishing individualized treatment.
Zhang et al. (Fri,) studied this question.